Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The one analyst offering a 12 month price target expects the share price price of Nektar Therapeutics to remain relatively unchanged over the next year.
High | 2.4% | 1.30 |
Med | 2.4% | 1.30 |
Low | 2.4% | 1.30 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | +0.38% |
Average growth rate | +10.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.96% |
Average growth rate | -2.93% |
More ▼